COVIDIEN $65.25

down -0.55


22/5/2013 04:22 PM  |  NYSE : COV  |  Industries : Manufacturing / Medical Equipment and Supplies Manufacturing
Last Trade: 65.25
Trade Time: May 22 4:07 PM Eastern Daylight Time
Change: -0.55 (-0.84 %)
Prev Close: 65.80
Open: 65.86
Bid: 65.12
Ask: 65.46
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN

ETF Alternatives



People viewing COV also viewed: , , , ,

Competitors

Ticker Name Volume % Change
VYTRQ VYTERIS 45.0K +1.90%
SLGTQ SURGILIGHT 375.9K +0.71%
LANZ LANCER ORTHODONTICS 13.5K +0.40%
TSON TRANS1 201.4K +0.13%
HRAL HEAR ATLAST HOLDINGS 50.0K +0.10%

Insider Transactions

Date Name Title Volume Trade Price Holding Change
5/8/2013 Clemmer James C Senior Vice President -29,260 $65.41 -54.71%
5/8/2013 Clemmer James C Senior Vice President 12,732 $46.45 31.24%
5/3/2013 HOGAN RANDALL J Director 8 $64.35 0.05%
5/3/2013 BROWN RICHARD G JR Vice President and Controller 15 $64.35 0.03%
5/3/2013 Madaus Martin D Director 8 $64.35 0.14%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (COV), click here.
View All

COV Stock Analysis

  1. It Gets A Little Harder From Here For Covidien

    (COV,JNJ,SYK,BCR,MDT,CSII,ISRG,CNMD,ABT )
    Expectations are the bigger issue for Covidien, as underlying growth is still pretty good on a relative basis.

  2. Is Controversy About Robot-Assisted Surgery Showing In Intuitive Surgical's Numbers?

    (ISRG,COV,JNJ,SYK,MAKO )
    Uncertainty about procedure growth may be opening a window in these often-expensive shares
  3.

    Pharma Is Doing All The Pulling For Johnson & Johnson

    (COV,ABT,JNJ,MDT,STJ,ISRG,SYK,RHHBY,ZMH,SNY )
    Although JNJ reported decent earnings and has some major new drugs lined up - downside risk is definitely still present.
  4.

    AngioDynamics Still Struggling To Get Back On Track

    (ANGO,BCR,COV,MMSI,VASC )
    Ongoing revenue growth struggles and eroding market share is making the deep-value case harder at AngioDynamics.
Free Reports
  1.

    Free Corn and Ethanol Report!

    Learn how you can take advantage of an ethanol-driven bull market in corn.
  2.

    Forbes Wolfe Nanotech Report Nanotech 101

    Get this Rare, First-Person Account of the Nanotechnology Industry, Absolutely Free!
  3.

    Forbes Quant Model: 3 Top Stocks

    Using Forbes’ exclusive Quant Model, we’ve chosen three stocks that we think could double in price in the next 12 months.
Marketplace
Trading Center